Pirjo Laakkonen - Concepedia

Author

Pirjo Laakkonen

University of Helsinki ORCID

Also Known As

P Laakkonen, P. Laakkonen, Pirjo Maarit Laakkonen, Pirjo Laakkonen, Pirjo M. Laakkonen, Prof Pirjo Laakkonen

238

Publications

8.5K

Citations

H-Index

Concepts

All Affiliations

University of Helsinki Helsinki University Hospital Sanford Burnham Prebys Medical Discovery Institute University of Eastern Finland Helsinki Institute of Physics

About

Pirjo Laakkonen is an author at University of Helsinki specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	28	3.2K
2	Engineering	8	8	434
3	Health Sciences	3	3	84
4	Natural Sciences	3	3	359
5	Biochemistry	1	1	108

Pirjo Laakkonen

Publications

7.7K

Citations

H-Index

Page 1

	Year	Citations
Nanocrystal targeting <i>in vivo</i> Maria E. Åkerman, Warren C. W. Chan, Pirjo Laakkonen, Proceedings of the National Academy of Sciences	2002	1.4K
Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation Tuomas Tammela, Georgia Zarkada, Elisabet Wallgard, Nature Vascular Network FormationAngiogenesisVascular BiologyNeovascularizationVascular Endothelial Growth Factor	2008	799
A tumor-homing peptide with a targeting specificity related to lymphatic vessels Pirjo Laakkonen, Kimmo Porkka, Jason A. Hoffman, Nature Medicine Tumor-homing PeptideLymphatic VesselsPeptide EngineeringPeptide LibraryImmunology	2002	491
Lymphatic Neoangiogenesis in Human Kidney Transplants Is Associated with Immunologically Active Lymphocytic Infiltrates Dontscho Kerjaschki, Heinrich M. Regele, Isabella Moosberger, Journal of the American Society of Nephrology	2004	476
Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels Sven Christian, Ján Pilch, Maria E. Åkerman, The Journal of Cell Biology	2003	474
A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells <i>in vivo</i> Kimmo Porkka, Pirjo Laakkonen, Jason A. Hoffman, Proceedings of the National Academy of Sciences	2002	285
Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells Pirjo Laakkonen, Maria E. Åkerman, Hector Biliran, Proceedings of the National Academy of Sciences Homing PeptideAntitumor ActivityImmunologyImmunoeditingLyp-1 Peptide	2004	274
Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis Johanna A. Joyce, Pirjo Laakkonen, Michele Bernasconi, Cancer Cell Phage DisplayPancreatic CancerPathologyStage-specific Vascular MarkersMouse Model	2003	251
Vascular Endothelial Growth Factor Receptor 3 Is Involved in Tumor Angiogenesis and Growth Pirjo Laakkonen, Marika Waltari, Tanja Holopainen, Cancer Research	2007	241
Characterization of the Rab8-specific membrane traffic route linked to protrusion formation Katarina Hattula, Johanna Furuhjelm, Jaana Tikkanen, Journal of Cell Science Membrane StructureRab8 Membrane DynamicsMolecular BiologyCytoskeletonCellular Physiology	2006	221

Page 1